Feb, 2013

U.S.A.
News / Therapeutic Area News
Astellas to Drive PGA TOUR's New Women's Initiative
The PGA TOUR and Astellas Pharma US, Inc. ("Astellas"), a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo:...
Read More
U.S.A.
News / Therapeutic Area News
Astellas Highlights Progress to Advance Care of Patients with Genitourinary Cancers at ASCO-GU Annual Meeting
NORTHBROOK, IL – February 13, 2013 -- Astellas Pharma US, Inc., a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), today announced that more than 10 abstracts from Astellas...
Read More
U.S.A.
News / Therapeutic Area News
Astellas Highlights Progress to Advance Care of Patients with Genitourinary Cancers at ASCO-GU Annual Meeting
Astellas Pharma US, Inc., a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), today announced that more than 10 abstracts from...
Read More
U.S.A.
News / Therapeutic Area News
AVEO and Astellas Report Final Overall Survival Results from TIVO-1
CAMBRIDGE, Mass. and TOKYO, Japan, February 12, 2013 - AVEO Oncology (NASDAQ: AVEO) and Astellas Pharma Inc. (TSE: 4503) today announced overall survival (OS) for tivozanib, an investigational...
Read More

Jan, 2013

U.S.A.
News / Therapeutic Area News
AVEO and Astellas Announce Presentations of Tivozanib Clinical Data at 2013 ASCO Genitourinary Cancers Symposium
CAMBRIDGE, Mass. and TOKYO, Japan, January 29, 2013 - AVEO Oncology (NASDAQ: AVEO) and Astellas Pharma Inc. (TSE: 4503) today announced that new clinical data on tivozanib, an investigational...
Read More